scispace - formally typeset
G

Giuseppina Bozzuto

Researcher at Istituto Superiore di Sanità

Publications -  28
Citations -  2207

Giuseppina Bozzuto is an academic researcher from Istituto Superiore di Sanità. The author has contributed to research in topics: Liposome & Cell migration. The author has an hindex of 14, co-authored 24 publications receiving 1648 citations.

Papers
More filters
Journal ArticleDOI

Liposomes as nanomedical devices

TL;DR: This review briefly analyze how the efficacy of liposomes depends on the nature of their components and their size, surface charge, and lipidic organization, and describes some strategies developed to overcome limitations of the “first-generation” liposome-based drugs on the market and in clinical trials.
Journal ArticleDOI

Molecular aspects of tumor cell migration and invasion

TL;DR: The balance of cellular signals for proliferation and survival responses also regulates migratory behaviours of tumor cells, and the scene of crime drug resistance players can interfere thus worsening this delicate situation.
Journal ArticleDOI

The multidrug transporter P-glycoprotein: a mediator of melanoma invasion?

TL;DR: A link was identified between MDR transporter Pgp, and MAPK signaling and invasion, and metalloproteinase mRNAs, and proteolytic activities, which are associated with an increased invasive behavior.
Journal ArticleDOI

Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model

TL;DR: The findings suggest that targeting CXCR4 by peptide R might represent a novel therapeutic approach against GBM, and contribute to the rationale to further explore in more complex pre-clinical settings the therapeutic potential of peptides R, alone or in combination with standard therapies of GBM.
Journal ArticleDOI

Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells

TL;DR: Results support a critical involvement of PC-PLC in controlling molecular pathways responsible for maintaining a mesenchymal-like phenotype in metastatic BC cells and suggests PC- PLC deactivation as a means to promote BC cell differentiation and possibly enhance the effectiveness of antitumor treatments.